search
UEG Week
Trends
- 1
Abivax shares climbed around 5% after positive feedback on its lead drug candidate obefazimod at UEG Week, a major European gastroenterology conference. The drug, being developed to treat ulcerative colitis, drew praise from specialists attending the meeting. Investors read the reception as a encouraging signal ahead of the treatment's further development and potential approval.
- 2Pancreatic Cancer Europe Attends UEG Week 2026▼Are You Here at UEG Week 2026? – Pancreatic Cancer Europe
Pancreatic Cancer Europe is attending UEG Week 2026, the major European gastroenterology congress, and is inviting attendees to connect with its team at the event. The organisation uses its presence to raise awareness of pancreatic cancer among specialists. The congress typically gathers thousands of clinicians and researchers to discuss advances in digestive diseases, including early detection and treatment of pancreatic cancer.